SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-15-000021
Filing Date
2015-11-12
Accepted
2015-11-12 16:15:00
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imdz930201510-q.htm 10-Q 871368
2 EXHIBIT 31.1 ex311imdz2015q3.htm EX-31.1 7590
3 EXHIBIT 31.2 ex312imdz2015q3.htm EX-31.2 7971
4 EXHIBIT 32.1 ex321imdz2015q3.htm EX-32.1 4817
5 EXHIBIT 32.2 ex322imdz2015q3.htm EX-32.2 5067
  Complete submission text file 0001437786-15-000021.txt   3526791

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20150930.xml EX-101.INS 545413
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20150930.xsd EX-101.SCH 29880
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20150930_cal.xml EX-101.CAL 42571
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20150930_def.xml EX-101.DEF 126258
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20150930_lab.xml EX-101.LAB 401708
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20150930_pre.xml EX-101.PRE 229738
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 151224983
SIC: 2834 Pharmaceutical Preparations